Subjects: United+States - Digital Collections - National Library of Medicine Search Results

Start Over Subjects United+States ✖

8021. Some Medicare Advantage Organization denials of prior authorization requests raise concerns about beneficiary access to medically necessary care

Publication:: Washington, DC : U.S. Department of Health and Human Services, Office of Inspector General, April 2022
Subject(s):: Government Regulation
Insurance, Health, Reimbursement -- economics
Medicare Part C -- economics
Medicare Part C -- organization & administration
Prior Authorization -- economics
Time-to-Treatment
United States
United States. Department of Health and Human Services

8022. Meeting America’s public health challenge: recommendations for building a national public health system that addresses ongoing and future health crises, advances equity, and earns trust

Publication:: [New York, New York] : The Commonwealth Fund, June 2022
Subject(s):: Health Planning
Public Health Administration
Federal Government
United States

8023. Status of U.S. health insurance coverage and policy levers to expand coverage and lower consumer costs: invited testimony : U.S. House of Representatives Committee on Oversight and Reform hearing on “Examining Pathways to Universal Health Coverage”

Author(s):: Collins, Sara R., author
Publication:: New York, NY : The Commonwealth Fund, March 29, 2022
Subject(s):: Cost Control
COVID-19 -- economics
Health Policy
Insurance Coverage -- economics
Insurance Coverage -- statistics & numerical data
Medicaid
Medically Uninsured -- statistics & numerical data
United States
United States.

8024. Appeal options available to mammography facilities concerning adverse accreditation decisions, suspension/revocation of certificates, or patient and physician notification orders: guidance for mammography facilities and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, March 2, 2022
Subject(s):: Accreditation
Facility Regulation and Control
Mammography
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

8025. COVID-19 public health emergency: policy on COVID-19-related sanitation tunnels : guidance for industry and investigators

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, February 2022
Subject(s):: COVID-19
Disinfection -- standards
Sanitation -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

8026. Nonclinical considerations for mitigating nonhuman primate supply constraints arising from the COVID-19 pandemic

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, February 2022
Subject(s):: Biological Products
Drug Evaluation, Preclinical
Primates
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

8027. Drug product tracing: the effect of section 585 of the FD&C Act : questions and answers

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, February 2022
Subject(s):: Prescription Drugs -- standards
Prescription Drugs -- supply & distribution
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

8028. Population pharmacokinetics

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, February 2022
Subject(s):: Clinical Trials as Topic
Drug Approval
Drug Development
Drugs, Investigational
Pharmacokinetics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

8029. Expansion cohorts: use in first-in-human clinical trials to expedite development of oncology drugs and biologics

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, March 2022
Subject(s):: Antineoplastic Agents
Biological Products
Clinical Trials as Topic
Drug Development -- legislation & jurisprudence
Drug Development -- standards
Medical Oncology
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

8030. Center for Devices and Radiological Health (CDRH) appeals processes: Guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, March 2, 2022
Subject(s):: Device Approval -- legislation & jurisprudence
Dissent and Disputes
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

« Previous
Next »
1
2
…
799
800
801
802
803
804
805
806
807
…
952
953